Resource Type
Protocol
Resource Name

Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS)
Canonical Identifier
doi:10.32113/cellr4_20204_2839
Description
A clinical protocol for a proposed early phase controlled, randomized clinical trial to treat COVID-19 patients with ALI/ARDS with umbilical cord-derived mesenchymal stem cells.
Contributors
NameOrganizationConsortiumContact
Camillo RicordiUniversity of MiamiCHIB, HPAC, CTAR Contact


Have you used this resource?





.